Confronting the Stigma of Opioid Use Disorder—and Its Treatment

Olsen, Yngvild; Sharfstein, Joshua M.

doi:10.1001/jama.2014.2147

Cited by 260 publications

(202 citation statements)

References 3 publications

Supporting

Mentioning

196

Contrasting

Unclassified

Order By: Relevance

“…Furthermore, the increases identified in this study occurred in the context of increasing heroin use and heroin-related overdose deaths in the United States, 39 supporting a need to address nonmedical use of prescription opioid and heroin abuse in a coordinated and comprehensive manner. 31,33,40 Conclusions During the 2003-2013 years, among adults aged 18 through 64 years, the percentage of nonmedical use of prescription opioids decreased. In contrast, the prevalence of prescription opioid use disorders, frequency of use, and related mortality increased.…”

Section: Radarsmentioning

confidence: 99%

Nonmedical Prescription Opioid Use and Use Disorders Among Adults Aged 18 Through 64 Years in the United States, 2003-2013

Han

Compton

Jones

et al. 2015

JAMA

323

242

View full text Add to dashboard Cite

show abstract

Section: Radarsmentioning

confidence: 99%

Nonmedical Prescription Opioid Use and Use Disorders Among Adults Aged 18 Through 64 Years in the United States, 2003-2013

Han

Compton

Jones

et al. 2015

JAMA

323

242

View full text Add to dashboard Cite

show abstract

“…Patients suffering from addiction have been battling this stigma and discrimination for decades. The common social sentiment, "Why don't these people stop doing drugs," is not just sewn into the fabric of our society, but has also permeated our healthcare system, treatment models, and our definitions of 'successful' treatment [12]. These beliefs are centered on a misguided understanding, which assumes that if a patient stops taking the opioid, then they are cured; however, this is not supported by the available evidence concerning detoxification and abstinence based treatment [13][14][15][16].…”

Section: Individualizing Opioid Use Disorder (Oud) Treatment: Time Tomentioning

confidence: 99%

Individualizing Opioid Use Disorder (OUD) Treatment: Time to Fully Embrace a Chronic Disease Model

Gustin¹,

Nichols²,

Martin³

2015

J Reward Defic Syndr

View full text Add to dashboard Cite

The current opioid epidemic in the United States is changing our perceptions of the face of addiction. Opioid Use Disorder (OUD) has become pervasive and is affecting all ethnicities, races, socioeconomic classes, the young and the old. In 2015, 46 people will lose their life each day to a chronic brain disease that is going unnoticed and undertreated. Over the last five decades, numerous scientific and clinical breakthroughs have allowed for a better understanding of the mechanisms underlying addiction, and the development of medications that can help support a patient's long-term recovery. All of those that have contributed to these advancements have aided in redefining addiction as a primary, chronic disease of the brain reward, motivation, memory and related circuitry; however, our treatment strategies have not necessarily advanced to the same extent as our current understanding of the disease. This commentary will explore how personal philosophies can bias treatments strategies and definitions of treatment success, and prevent adoption of chronic disease treatment models that would significantly improve the quality of life of those suffering with OUD. This is a challenge to consider how our views and stigma can impact a patient's recovery. We are currently losing a battle with a disease that is taking the lives of 46 individuals daily; it is time to fully embrace a chronic disease model which comprises an integrated pharmacopsychosocial approach for treating the biopsychosocial disorder that is addiction to reverse these trends.

show abstract

“…16 The patients in this program were exceptionally satisfied with their treatment. 16 They cited high-quality medical care, enhanced confidentiality, reduced feelings of stigmatization, 29,30 freedom to move to a more desirable location, greater employment opportunities, and ability to take vacations, among other benefits.…”

Section: New Yorkmentioning

confidence: 99%

Methadone Medical Maintenance: An Early 21st-Century Perspective

Novick

Salsitz

Joseph

et al. 2015

Journal of Addictive Diseases

View full text Add to dashboard Cite

Methadone medical maintenance is the treatment of stable methadone-maintained patients in primary care physicians' offices under an exemption from federal methadone regulations. Reports from seven such programs in six states show high retention and low frequencies of illicit drug use. Patients and physicians indicate high levels of satisfaction. Although methadone maintenance has a long history of safety and efficacy, most methadone medical maintenance programs are no longer operating or accepting new patients. Federal regulations for standard methadone clinics allow some features of methadone medical maintenance, and advocacy for state approval of these changes is strongly recommended.

show abstract

Confronting the Stigma of Opioid Use Disorder—and Its Treatment

Cited by 260 publications

References 3 publications

Nonmedical Prescription Opioid Use and Use Disorders Among Adults Aged 18 Through 64 Years in the United States, 2003-2013

Nonmedical Prescription Opioid Use and Use Disorders Among Adults Aged 18 Through 64 Years in the United States, 2003-2013

Individualizing Opioid Use Disorder (OUD) Treatment: Time to Fully Embrace a Chronic Disease Model

Methadone Medical Maintenance: An Early 21st-Century Perspective

Contact Info

Product

Resources

About